Deutsche Bank’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,714
| Closed | -$78K | – | 4796 |
|
|
2021
Q1 | $78K | Sell |
10,714
-1,007
| -9% | -$7.33K | ﹤0.01% | 4019 |
|
|
2020
Q4 | $90K | Buy |
11,721
+4,681
| +66% | +$35.9K | ﹤0.01% | 3822 |
|
|
2020
Q3 | $64K | Buy |
7,040
+585
| +9% | +$5.32K | ﹤0.01% | 3698 |
|
|
2020
Q2 | $55K | Buy |
6,455
+3,608
| +127% | +$30.7K | ﹤0.01% | 3717 |
|
|
2020
Q1 | $14K | Sell |
2,847
-2,656
| -48% | -$13.1K | ﹤0.01% | 3876 |
|
|
2019
Q4 | $38K | Buy |
5,503
+3,095
| +129% | +$21.4K | ﹤0.01% | 3952 |
|
|
2019
Q3 | $24K | Sell |
2,408
-4,118
| -63% | -$41K | ﹤0.01% | 4095 |
|
|
2019
Q2 | $83K | Sell |
6,526
-3,686
| -36% | -$46.9K | ﹤0.01% | 4146 |
|
|
2019
Q1 | $99K | Sell |
10,212
-976
| -9% | -$9.46K | ﹤0.01% | 4173 |
|
|
2018
Q4 | $115K | Buy |
+11,188
| New | +$115K | ﹤0.01% | 4019 |
|